Hello and welcome to Aaj Ki Baat With Rajat Sharma, the only news show with real facts and no noise.
An oral drug for treating COVID-19 could be ready next year, Pfizer CEO Albert Bourla has said.
Covid-19 vaccination drive for those above 18 will not begin from May 1 in Maharashtra. The government, however, said that it will provide vaccine free of cost to all
One in four people experience mild, short lived systemic side effects after receiving either the COVID-19 preventive by Pfizer or AstraZeneca vaccine -- known as Covishield in India -- with headache, fatigue and tenderness the most common symptoms, according to a study published in the Lancet Infectious Diseases journal.
Those given a first dose of either of the two vaccines currently being administered by the National Health Service (NHS) and who became infected with SARS-Cov-2 – the coronavirus which causes COVID-19 – three weeks later were between 38 and 49 per cent less likely to pass the virus on than unvaccinated people.
Registration for the new eligible population groups (all those above 18 years) will start on Wednesday from 4 pm. Vaccination against COVID-19 began in the country on January 16.
Healthcare facilities across Hyderabad are ramping up their capacity to vaccinate more population in the weeks ahead. They believe vaccination for all is the most definitive step in the fight against coronavirus.
Maharashtra remains one of the worst-COVID-affected states in the country. As many as 66,358 new cases, 895 deaths and 67,752 recoveries were reported on Tuesday. The total case tally stands at 44,100,85.
Amid deadly Covid-19 second wave surge, the Centre had said that all Indian adults will be eligible to receive the Covid-19 vaccine starting May 1. Here's how and where you can register yourself & your family members for the third phase of Covid-19 vaccination
People, who came to take the Covid-19 jab waited outside Mumbai's Bandra Kurla Complex (BKC) jumbo vaccination centre after the vaccines ran out of stock. Boards reading 'Vaccine out of stock' were put up outside the BKC centre.
Maharashtra has demanded 12 crore vaccine doses of Covishield from the Serum Institute of India.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus. The other two vaccines are Covaxin and Covishield.
The pre-clinical trial of the nasal Covid-19 vaccine candidate, BBV154 has already started. If all goes as expected, the clinical trial would be completed by June and it could become available in the market by August.
Total vaccination across the country has crossed over 14.5 crore with more than 31 lakh doses of COVID-19 vaccine administered till 8 pm on Monday, the Health Ministry said.
India's health infrastructure has been buckling under pressure with an unprecedented surge in Covid-19 cases in the last two weeks. The country's coronavirus cases hit a new record on Monday with 3,52,991 new cases, along with 2,812 deaths.
In a letter to the sales agents on Monday, the Sichuan Chuanhang Logistics Co. Ltd, the company which is part of the Sichuan Airlines said the airline has suspended its cargo flights on six routes, including Xian to Delhi, amid hectic efforts by private traders from both sides to procure oxygen concentrators from China.
The vaccination process through GOI route will continue as before and the entire expense of this will continue to be borne by the Centre. As the eligibility criteria to get vaccinated through this route evolves further, GOI will continue to provide full support to the states to vaccinate all eligible people free of cost.
India has been reporting high number of Covid-19 cases and deaths while several reports of shortage of oxygen are also coming.
Rajasthan will provide free Covid vaccination for people above 18 years of age, Chief Minister Ashok Gehlot announced on Sunday.
Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday.